RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Need satisfaction and catastrophizing: explaining the relationship among emotional ambivalence, pain, and depressive symptoms.

Recent literature has revealed the associations among ambivalence over emotional expression (AEE), pain, and depressive symptoms. However, few studies have examined factors explaining these associations. The goal of the study is to examine the potential mediating role of basic needs and pain catastrophizing. In an ethnically diverse undergraduate sample (N = 255), we found that AEE was positively associated with both depressive symptoms and pain. Catastrophizing fully mediated the association between AEE and pain, while catastrophizing and unfulfilled needs partially mediated the association between AEE and depression. Findings suggest that need satisfaction and catastrophizing are important factors in understanding AEE and its health implications.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app